101 related articles for article (PubMed ID: 16594642)
21. Development and validation of enzyme-linked immunosorbent assays for quantification of anti-methotrexate IgG and Fab in mouse and rat plasma.
Tayab ZR; Balthasar JP
J Immunoassay Immunochem; 2004; 25(4):335-44. PubMed ID: 15552588
[TBL] [Abstract][Full Text] [Related]
22. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747
[TBL] [Abstract][Full Text] [Related]
23. Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.
Tremblay T; Aubin E; Lemieux R; Bazin R
Br J Haematol; 2007 Oct; 139(2):297-302. PubMed ID: 17897306
[TBL] [Abstract][Full Text] [Related]
24. Application of pharmacokinetic-pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice.
Lobo ED; Soda DM; Balthasar JP
J Pharm Sci; 2003 Aug; 92(8):1665-76. PubMed ID: 12884253
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
Tremblay T; Paré I; Bazin R
Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
[TBL] [Abstract][Full Text] [Related]
27. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
28. The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patients.
Tosetto A; Ruggeri M; Schiavotto C; Pellizzari G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):41-6. PubMed ID: 8039757
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between the expression of autoantibodies against platelet membrane glycoprotein and therapeutic effect in primary immune thrombocytopenia].
Liu XF; Xue F; Zhang L; Zhou XL; Liu YZ; Liu W; Chen YF; Huang YT; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):610-3. PubMed ID: 23906456
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Implications of a Specific Murine Monoclonal Antibody (7E3) to the Platelet Receptor GPIIb/IIIa.
Bhattacharya S; Machin SJ; Lahiri A
Platelets; 1992; 3(3):119-24. PubMed ID: 21043903
[TBL] [Abstract][Full Text] [Related]
31. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years.
Yildiz I; Ozdemir N; Celkan T; Soylu S; Karaman S; Canbolat A; Dogru O; Erginoz E; Apak H
Pediatr Hematol Oncol; 2015; 32(6):406-14. PubMed ID: 26154620
[TBL] [Abstract][Full Text] [Related]
32. Role of complement-derived peptides in thrombocytopenia elicited by soluble aggregates of immunoglobulin G in the rat.
Fernandez-Gallardo S; Gijon MA; Furio V; Vivanco F; Crespo MS
Lab Invest; 1989 May; 60(5):705-13. PubMed ID: 2716283
[TBL] [Abstract][Full Text] [Related]
33. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.
Sassoli PM; Emmell EL; Tam SH; Trikha M; Zhou Z; Jordan RE; Nakada MT
Thromb Haemost; 2001 May; 85(5):896-902. PubMed ID: 11372685
[TBL] [Abstract][Full Text] [Related]
34. Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat.
Barrett JS; Wagner JG; Fisher SJ; Wahl RL
Cancer Res; 1991 Jul; 51(13):3434-44. PubMed ID: 1905196
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia.
Leytin V; Mykhaylov S; Starkey AF; Allen DJ; Lau H; Ni H; Semple JW; Lazarus AH; Freedman J
Br J Haematol; 2006 Apr; 133(1):78-82. PubMed ID: 16512832
[TBL] [Abstract][Full Text] [Related]
36. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
Crow AR; Amash A; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
[TBL] [Abstract][Full Text] [Related]
37. Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.
Liebman HA; Saleh MN; Bussel JB; Negrea OG; Horne H; Wegener WA; Goldenberg DM
Br J Haematol; 2013 Sep; 162(5):693-701. PubMed ID: 23829485
[TBL] [Abstract][Full Text] [Related]
38. Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiency.
Longhurst HJ; O'Grady C; Evans G; De Lord C; Hughes A; Cavenagh J; Helbert MR
J Clin Pathol; 2002 Jan; 55(1):64-6. PubMed ID: 11825928
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects.
Yu X; Menard M; Seabright G; Crispin M; Lazarus AH
Transfusion; 2015 Jun; 55(6 Pt 2):1501-11. PubMed ID: 25752470
[TBL] [Abstract][Full Text] [Related]
40. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
